Miravant Medical Technologies (Miravant Medical Technologies) Enterprise Value : $0.00 Mil (As of May. 27, 2024)

Miravant Medical Technologies Enterprise Value Chart

Miravant Medical Technologies Annual Data
	Trend	Dec95	Dec96	Dec97	Dec98	Dec99	Dec00	Dec01	Dec02	Dec03	Dec04
Enterprise Value		Get a 7-Day Free Trial					174.74	200.32	32.85	39.39	41.32

Miravant Medical Technologies Quarterly Data
	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05
Enterprise Value	Get a 7-Day Free Trial															60.54	41.32	39.14	28.07	27.78

Competitive Comparison of Miravant Medical Technologies's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Miravant Medical Technologies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Miravant Medical Technologies's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Miravant Medical Technologies's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Miravant Medical Technologies's Enterprise Value falls into.

Miravant Medical Technologies Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Miravant Medical Technologies's Enterprise Value for the fiscal year that ended in Dec. 2004 is calculated as

Miravant Medical Technologies's Enterprise Value for the quarter that ended in Sep. 2005 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Miravant Medical Technologies  (OTCPK:MRVT) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Miravant Medical Technologies's EV-to-EBIT for today is

Miravant Medical Technologies's current Enterprise Value is $0.00 Mil.
Miravant Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Sep. 2005 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.57 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Miravant Medical Technologies's EV-to-EBITDA for today is:

Miravant Medical Technologies's current Enterprise Value is $0.00 Mil.
Miravant Medical Technologies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2005 adds up the quarterly data reported by the company within the most recent 12 months, which was $-13.33 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Miravant Medical Technologies's EV-to-Revenue for today is:

Miravant Medical Technologies's current Enterprise Value is $0.00 Mil.
Miravant Medical Technologies's Revenue for the trailing twelve months (TTM) ended in Sep. 2005 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Miravant Medical Technologies Enterprise Value Related Terms

Thank you for viewing the detailed overview of Miravant Medical Technologies's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Miravant Medical Technologies (Miravant Medical Technologies) Business Description